EVP-6124, a selective alpha-7 partial agonist, has positive effects on cognition and clinical function in mild-to-moderate Alzheimer's disease patients: Results of a six-month, double-blind, placebo controlled, dose ranging study

✍ Scribed by Hilt, Dana; Gawryl, Maria; Koenig, Gerhard; Dgetluck, Nancy; Moebius, Hans

• Book ID: 122274455
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 49 KB
• Volume: 8
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2013.08.030